These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39140696)

  • 1. Congenital Hypodysfibrinogenemia due to γ326Cys→Tyr Mutation: Third Ever-Described Case Associated with Recurrent Venous Thrombosis and COVID Vaccine.
    Nanthan KR; Pedersen IS; Andersen DT; Bor MV
    Acta Haematol; 2024; 147(5):564-570. PubMed ID: 39140696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
    Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.
    Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27832. PubMed ID: 31131962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fibrinogen γ chain frameshift deletion (c.637delT) in a patient with hypodysfibrinogenemia associated with thrombosis.
    Ivaškevičius V; Thomas A; Biswas A; Ensikat H; Schmitt U; Horneff S; Pavlova A; Poetzsch B; Oldenburg J
    Hamostaseologie; 2015; 35 Suppl 1():S27-31. PubMed ID: 26540127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.
    Zhu L; Zhao M; Wang M; Lou Z; Chen X; Pan L; Yu D; Xia W; Wang H; Zhou B; Gao S
    J Thromb Thrombolysis; 2018 Aug; 46(2):211-218. PubMed ID: 29748775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female.
    Guglielmone HA; Bastos L; Jarchum GD; Alvarez-Bollea MA
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):80-84. PubMed ID: 30632992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
    Keller MA; Martinez J; Baradet TC; Nagaswami C; Chernysh IN; Borowski MK; Surrey S; Weisel JW
    Blood; 2005 Apr; 105(8):3162-8. PubMed ID: 15632207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense mutation (FGG c.1168G > T) in the gamma chain of fibrinogen causing congenital hypodysfibrinogenemia with bleeding phenotype.
    Xu N; Zheng L; Dai Z; Zhu J; Xie P; Yang S; Chen F
    Hereditas; 2024 Jan; 161(1):4. PubMed ID: 38233949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
    Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
    Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.
    Nowak-Göttl U; Weiler H; Hernandez I; Thedieck S; Seehafer T; Schulte T; Stoll M
    Blood; 2009 Aug; 114(9):1947-53. PubMed ID: 19515723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.